menu
    • menu

    Company profile for Ankyra Therapeutics

    NEW Drugs in Dev: 2
    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Virtual Booth

    Contact Supplier

    Lupin Manufacturing Solutions – delivering high-quality APIs & end-to-end CDMO services for faster, cost-effective drug development.

    Virtual Booth

    Contact Supplier

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-2026-02-09

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Ankyra is developing a platform to significantly improve both the safety and efficacy of cytokine immunotherapies for cancer. Systemic dosing of these powerful immune stimulants has historically been limited by broad immune activation and toxicity. We have developed methods to localize cytokines specifically and persistently within tumors thereby creating intense hot spots of inflammation that activate a comprehensive anti-tum...
    Ankyra is developing a platform to significantly improve both the safety and efficacy of cytokine immunotherapies for cancer. Systemic dosing of these powerful immune stimulants has historically been limited by broad immune activation and toxicity. We have developed methods to localize cytokines specifically and persistently within tumors thereby creating intense hot spots of inflammation that activate a comprehensive anti-tumor immune response. Our mission is to translate this approach into the clinic and demonstrate superior efficacy compared to available options.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Ankyra TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    83 Newbury Street 4th Floor Boston, MA 02116
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://ankyratx.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/ankyratx/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Clinical Outsourcing

    Clinical Outsourcing

    Not Confirmed

    envelop Contact Supplier

    Clinical Outsourcing

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    At AACR IO Meeting: Ankyra Therapeutics Unveils ANK-203 Data
    At AACR IO Meeting: Ankyra Therapeutics Unveils ANK-203 Data

    18 Feb 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260218457872/en/Ankyra-Therapeutics-Presents-First-Preclinical-Data-on-ANK-203-a-Novel-CD137-Anchored-Immunotherapy-Candidate-in-Oral-Session-at-AACR-IO

    BUSINESSWIRE
    18 Feb 2026
    Share Share
    Ankyra Names Sailaja Battula, Phd Chief Scientific Officer
    Ankyra Names Sailaja Battula, Phd Chief Scientific Officer

    15 Dec 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251215507385/en/Ankyra-Appoints-Sailaja-Battula-PhD-as-Chief-Scientific-Officer-CSO

    BUSINESSWIRE
    15 Dec 2025
    Share Share
    Ankyra Therapeutics Launches Phase 1b Lung Cancer Trial
    Ankyra Therapeutics Launches Phase 1b Lung Cancer Trial

    17 Nov 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251117754232/en/Ankyra-Therapeutics-Announces-First-Patient-Dosed-in-Phase-1b-Trial-Evaluating-First-in-Class-Anchored-Immunotherapy-in-Combination-with-Immune-Checkpoint-Blockade-in-Patients-with-Lung-Cancer

    BUSINESSWIRE
    17 Nov 2025
    Share Share
    Ankyra To Present Phase 1 Clinical Data At SITC Annual Meeting
    Ankyra To Present Phase 1 Clinical Data At SITC Annual Meeting

    04 Nov 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251104335799/en/Ankyra-Announces-Publication-of-Phase-1-Clinical-Data-and-Will-Present-at-the-Society-for-Immunotherapy-of-Cancer-SITC-Annual-Meeting

    BUSINESSWIRE
    04 Nov 2025
    Share Share
    Ankyra Therapeutics reveals Phase 1 data at 2025 AACR Meeting
    Ankyra Therapeutics reveals Phase 1 data at 2025 AACR Meeting

    28 Apr 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250428550798/en/Ankyra-Therapeutics-Announces-Phase-1-Clinical-Data-at-the-2025-AACR-Annual-Meeting-and-the-first-patient-has-been-dosed-with-tolododekin-alfa-and-cemiplimab

    BUSINESSWIRE
    28 Apr 2025
    Share Share
    Ankyra Doses First Visceral Tumor Patient in Phase 1 ANCHOR Trial
    Ankyra Doses First Visceral Tumor Patient in Phase 1 ANCHOR Trial

    05 Nov 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20241105939527/en

    BUSINESSWIRE
    05 Nov 2024
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search